MRNACT Trademark

Trademark Overview


On Wednesday, May 19, 2021, a trademark application was filed for MRNACT with the United States Patent and Trademark Office. The USPTO has given the MRNACT trademark a serial number of 90720622. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, December 10, 2024. This trademark is owned by Seqirus Inc.. The MRNACT trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals

Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use

Medical services; medical information; providing a website featuring medical information

Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

General Information


Serial Number90720622
Word MarkMRNACT
Filing DateWednesday, May 19, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and ServicesVaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals
Goods and ServicesActive chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use
Goods and ServicesMedical services; medical information; providing a website featuring medical information
Goods and ServicesPharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, March 1, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSeqirus Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHolly Springs, NC 27540

Party NameSeqirus Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHolly Springs, NC 27540

Trademark Events


Event DateEvent Description
Saturday, May 22, 2021NEW APPLICATION ENTERED
Tuesday, August 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 31, 2022ASSIGNED TO EXAMINER
Friday, February 4, 2022NON-FINAL ACTION WRITTEN
Friday, February 4, 2022NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 31, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 31, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 1, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 1, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, March 1, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 1, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, March 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 21, 2023SOU EXTENSION 1 FILED
Tuesday, November 21, 2023SOU EXTENSION 1 GRANTED
Thursday, November 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 22, 2024SOU EXTENSION 2 FILED
Wednesday, May 22, 2024SOU EXTENSION 2 GRANTED
Thursday, May 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2024SOU EXTENSION 3 FILED
Tuesday, November 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 11, 2024SOU EXTENSION 3 GRANTED
Wednesday, December 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED